Blatt LM - Search Results

1

The clinical utility of using Catrimox-14-treated whole blood in detecting hepatitis C virus RNA.

Patel K, Albrecht J, Owens E, Dev A, Heaton S, Pianko S, Pockros PJ, Conrad A, Blatt LM, McHutchison JG. Patel K, et al. Among authors: blatt lm. Antivir Ther. 2005;10(4):535-41. Antivir Ther. 2005. PMID: 16038479

2

Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C.

Patel K, Lajoie A, Heaton S, Pianko S, Behling CA, Bylund D, Pockros PJ, Blatt LM, Conrad A, McHutchison JG. Patel K, et al. Among authors: blatt lm. J Gastroenterol Hepatol. 2003 Mar;18(3):253-7. doi: 10.1046/j.1440-1746.2003.02930.x. J Gastroenterol Hepatol. 2003. PMID: 12603524

3

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.

Patton HM, Patel K, Behling C, Bylund D, Blatt LM, Vallée M, Heaton S, Conrad A, Pockros PJ, McHutchison JG. Patton HM, et al. Among authors: blatt lm. J Hepatol. 2004 Mar;40(3):484-90. doi: 10.1016/j.jhep.2003.11.004. J Hepatol. 2004. PMID: 15123364

4

HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C.

Patel K, Norris S, Lebeck L, Feng A, Clare M, Pianko S, Portmann B, Blatt LM, Koziol J, Conrad A, McHutchison JG. Patel K, et al. Among authors: blatt lm. Hepatology. 2006 Feb;43(2):241-9. doi: 10.1002/hep.21040. Hepatology. 2006. PMID: 16440356

5

Relationship of smoking and fibrosis in patients with chronic hepatitis C.

Dev A, Patel K, Conrad A, Blatt LM, McHutchison JG. Dev A, et al. Among authors: blatt lm. Clin Gastroenterol Hepatol. 2006 Jun;4(6):797-801. doi: 10.1016/j.cgh.2006.03.019. Epub 2006 May 6. Clin Gastroenterol Hepatol. 2006. PMID: 16682255

6

Ultracentrifugation and concentration of a large volume of serum for HCV RNA during treatment may predict sustained and relapse response in chronic HCV infection.

McHutchison JG, Blatt LM, Ponnudurai R, Goodarzi K, Russell J, Conrad A. McHutchison JG, et al. Among authors: blatt lm. J Med Virol. 1999 Apr;57(4):351-5. J Med Virol. 1999. PMID: 10089045

7

Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.

Pianko S, McHutchison JG, Gordon SC, Heaton S, Goodman ZD, Patel K, Cortese CM, Brunt EM, Bacon BR, Blatt LM. Pianko S, et al. Among authors: blatt lm. J Interferon Cytokine Res. 2002 Apr;22(4):483-9. doi: 10.1089/10799900252952271. J Interferon Cytokine Res. 2002. PMID: 12034031 Clinical Trial.

8

Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chronic HCV infection?

McHutchison J, Blatt L, Sedghi-Vaziri A, Russell J, Schmid P, Conrad A. McHutchison J, et al. J Hepatol. 1998 Sep;29(3):362-8. doi: 10.1016/s0168-8278(98)80052-4. J Hepatol. 1998. PMID: 9764981

9

Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers.

Blatt LM, Tong MJ, McHutchison JG, Russell J, Schmid P, Conrad A. Blatt LM, et al. J Interferon Cytokine Res. 1998 Feb;18(2):75-80. doi: 10.1089/jir.1998.18.75. J Interferon Cytokine Res. 1998. PMID: 9506457

10

A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infection.

McHutchison JG, Giannelli G, Nyberg L, Blatt LM, Waite K, Mischkot P, Pianko S, Conrad A, Grint P. McHutchison JG, et al. Among authors: blatt lm. J Interferon Cytokine Res. 1999 Nov;19(11):1265-70. doi: 10.1089/107999099312939. J Interferon Cytokine Res. 1999. PMID: 10574619 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters